Terms ending in 2036
Every in-force patent on Chemocentryx, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,783,540 | Substituted Tetrahydropyrans as CCR2 Modulators In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 10,464,934 | Substituted Tetrahydropyrans as CCR2 Modulators In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 12,054,484 | Substituted Tetrahydropyrans as CCR2 Modulators In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 9,809,581 | Inhibitors of CXCR2 In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 9,834,545 | Modulators of Chemokine Receptors In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 10,336,736 | Modulators of Chemokine Receptors In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 10,370,363 | Inhibitors of CXCR2 In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 10,988,464 | Modulators of Chemokine Receptors In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 11,040,960 | Inhibitors of CXCR2 In force · High confidence | Chemocentryx, Inc. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.